eli lilly ltlly sell elizabeth arden unit eli lilly board decide sell elizabeth arden inc wholly own subsidiary manufacture market cosmetic fine fragrance product business sale 67 mln dlrs acquire 1971 sale year 398 mln dlrs 12 pct 1985 operating profit 33 mln dlrs 1986 lilly retain morgan stanley evaluate offer lilly expect aftertax proceed sale cosmetic business general corporate purpose include repurchase time time common stock warrant open market statement lilly chairman richard wood this strategic decision reach basis belief future corporation resource include research activity focus business high technology life science orientation